American Financial Group heads into Q2 earnings season with Street sentiment quietly improving, an options market skewed firmly to the call side, and short interest too thin to drive the narrative on its own.
The most telling move this week came from Keefe, Bruyette & Woods, which raised its price target on AFG to $148 from $140 on July 8 while keeping its Market Perform rating — a target lift that now sits just above the current price of $142.80. That makes KBW the second firm to revise targets higher in recent weeks, following Piper Sandler's May raise to $140. Wells Fargo remains the most constructive, holding an Overweight with a $158 target. The mean target across the five covering analysts works out to roughly $143, leaving almost no headline upside but reflecting a group that is directionally more positive than it was six months ago — targets have moved from the $120s and $130s to the upper $130s and $140s. The hold-heavy consensus (five of five on hold or equivalent) frames AFG as a name the Street respects but isn't in a rush to chase.
Options positioning reinforces that picture, but with a notably bullish tilt. The put/call ratio has dropped to 0.23, well below its 20-day average of 0.29, and the pattern has been consistent — PCR has been running in the low 0.20s for most of the past three weeks, a sharp step down from the 0.40 range that dominated late May and early June. That shift means options flow is heavily call-weighted right now, more so than at almost any point in the past year (the 52-week low is 0.00, but the sustained sub-0.25 reading is unusual relative to recent history). The z-score of -0.75 is not extreme, but the direction of travel is clear: the options market has moved away from hedging and toward outright upside positioning. Borrow conditions add nothing to the tension here — availability is vast at roughly 4,394% of short interest, meaning lendable supply dwarfs what has been borrowed by an enormous margin, and cost to borrow is barely above zero at 0.51%.
Short interest, at 2.5% of free float, is low enough to be a non-factor in either direction. The level has crept up about 30% over the past month — from roughly 1.6 million shares in early June to just over 2.1 million now — but in absolute terms this remains a modest position against the free float, and with borrow this cheap and available, there is no squeeze dynamic to speak of. The ORTEX short score of 35.8 sits in the lower half of the range, consistent with a name that shorts are not pressing hard.
The bull case rests on premium growth and pricing. Net written premiums are projected to grow around 3% in 2025 and 5% in 2026, and the P&C sector broadly is expected to see improving core loss ratios as the pricing cycle matures. AFG trades at roughly 11.9x trailing earnings and 2.2x book — not obviously cheap, but reasonable for a specialty insurer with disciplined underwriting. The dividend score ranks in the 87th percentile relative to peers, reflecting the company's history of paying regular and special dividends (though the most recent dividend data in ORTEX predates 2023 and should be verified independently). The bear case centres on EPS estimates that have been revised down — projections for 2025 and 2026 have slipped from $10.10/$12.05 to $9.90/$11.85 — driven by higher anticipated loss ratios and softer net investment income. That compression is modest but worth tracking ahead of the August 4 Q2 print.
Recent earnings reactions have been muted. The last four prints produced next-day moves ranging from -1.4% to +1.7%, with five-day drifts equally contained. Closest peers have had a strong week — HIG is up over 4.5% on the week, AXS up more than 5%, and EG and TRV both up around 3.5%. AFG's 2% weekly gain lags that peer group, suggesting the stock has not fully participated in the sector's recent move. Whether the KBW target raise and the call-heavy options market are pricing in a catch-up trade ahead of August 4 is the question worth watching into earnings.
See the live data behind this article on ORTEX.
Open AFG on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
